These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28085026)

  • 61. The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2beta.
    Bibby AC; Litchfield DW
    Int J Biol Sci; 2005; 1(2):67-79. PubMed ID: 15951851
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hydration Structures of the Human Protein Kinase CK2α Clarified by Joint Neutron and X-ray Crystallography.
    Shibazaki C; Arai S; Shimizu R; Saeki M; Kinoshita T; Ostermann A; Schrader TE; Kurosaki Y; Sunami T; Kuroki R; Adachi M
    J Mol Biol; 2018 Dec; 430(24):5094-5104. PubMed ID: 30359582
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phosphorylation of thymidylate synthase from various sources by human protein kinase CK2 and its catalytic subunits.
    Fraczyk T; Kubiński K; Masłyk M; Cieśla J; Hellman U; Shugar D; Rode W
    Bioorg Chem; 2010 Jun; 38(3):124-31. PubMed ID: 20199796
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.
    Raaf J; Brunstein E; Issinger OG; Niefind K
    Chem Biol; 2008 Feb; 15(2):111-7. PubMed ID: 18291315
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of the N-terminal domain in the regulation of the "constitutively active" conformation of protein kinase CK2α: insight from a molecular dynamics investigation.
    Cristiani A; Costa G; Cozza G; Meggio F; Scapozza L; Moro S
    ChemMedChem; 2011 Jul; 6(7):1207-16. PubMed ID: 21591262
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A fragment-based approach leading to the discovery of inhibitors of CK2α with a novel mechanism of action.
    Brear P; De Fusco C; Atkinson EL; Iegre J; Francis-Newton NJ; Venkitaraman AR; Hyvönen M; Spring DR
    RSC Med Chem; 2022 Nov; 13(11):1420-1426. PubMed ID: 36426237
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight.
    Lolli G; Cozza G; Mazzorana M; Tibaldi E; Cesaro L; Donella-Deana A; Meggio F; Venerando A; Franchin C; Sarno S; Battistutta R; Pinna LA
    Biochemistry; 2012 Aug; 51(31):6097-107. PubMed ID: 22794353
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells.
    Yao K; Youn H; Gao X; Huang B; Zhou F; Li B; Han H
    Prostate; 2012 Sep; 72(13):1423-30. PubMed ID: 22290244
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Second-generation CK2α inhibitors targeting the αD pocket.
    Iegre J; Brear P; De Fusco C; Yoshida M; Mitchell SL; Rossmann M; Carro L; Sore HF; Hyvönen M; Spring DR
    Chem Sci; 2018 Mar; 9(11):3041-3049. PubMed ID: 29732088
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Structural insights for producing CK2α1-specific inhibitors.
    Tsuyuguchi M; Nakaniwa T; Hirasawa A; Nakanishi I; Kinoshita T
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126837. PubMed ID: 31859160
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocket.
    Bancet A; Frem R; Jeanneret F; Mularoni A; Bazelle P; Roelants C; Delcros JG; Guichou JF; Pillet C; Coste I; Renno T; Battail C; Cochet C; Lomberget T; Filhol O; Krimm I
    iScience; 2024 Feb; 27(2):108903. PubMed ID: 38318383
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate.
    Fabbian S; Giachin G; Bellanda M; Borgo C; Ruzzene M; Spuri G; Campofelice A; Veneziano L; Bonchio M; Carraro M; Battistutta R
    Front Mol Biosci; 2022; 9():906390. PubMed ID: 35720133
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Specific inhibition of CK2α from an anchor outside the active site.
    Brear P; De Fusco C; Hadje Georgiou K; Francis-Newton NJ; Stubbs CJ; Sore HF; Venkitaraman AR; Abell C; Spring DR; Hyvönen M
    Chem Sci; 2016 Nov; 7(11):6839-6845. PubMed ID: 28451126
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structural and Enzymological Evidence for an Altered Substrate Specificity in Okur-Chung Neurodevelopmental Syndrome Mutant CK2α
    Werner C; Gast A; Lindenblatt D; Nickelsen A; Niefind K; Jose J; Hochscherf J
    Front Mol Biosci; 2022; 9():831693. PubMed ID: 35445078
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design.
    Cozza G
    Pharmaceuticals (Basel); 2017 Feb; 10(1):. PubMed ID: 28230762
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α.
    Brear P; Ball D; Stott K; D'Arcy S; Hyvönen M
    J Med Chem; 2020 Nov; 63(21):12786-12798. PubMed ID: 33119282
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Crystal structure of Arabidopsis thaliana casein kinase 2 α1.
    Demulder M; De Veylder L; Loris R
    Acta Crystallogr F Struct Biol Commun; 2020 Apr; 76(Pt 4):182-191. PubMed ID: 32254052
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α' Structures.
    Lindenblatt D; Nickelsen A; Applegate VM; Hochscherf J; Witulski B; Bouaziz Z; Marminon C; Bretner M; Le Borgne M; Jose J; Niefind K
    ACS Omega; 2019 Mar; 4(3):5471-5478. PubMed ID: 31559376
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A Network Pharmacology-Based Approach to Investigate the Novel TCM Formula against Huntington's Disease and Validated by Support Vector Machine Model.
    Dai W; Chen HY; Chen CY
    Evid Based Complement Alternat Med; 2018; 2018():6020197. PubMed ID: 30643534
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'.
    Hochscherf J; Lindenblatt D; Witulski B; Birus R; Aichele D; Marminon C; Bouaziz Z; Le Borgne M; Jose J; Niefind K
    Pharmaceuticals (Basel); 2017 Dec; 10(4):. PubMed ID: 29236079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.